News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
622,524 Results
Type
Article (30503)
Company Profile (242)
Press Release (591773)
Multimedia
Podcasts (135)
Webinars (12)
Section
Business (197449)
Career Advice (477)
Deals (30085)
Drug Delivery (111)
Drug Development (76037)
Employer Resources (43)
FDA (14263)
Job Trends (11382)
News (295458)
Policy (24133)
Tag
2025 Best Places to Work (3)
2026 Best Places to Work (5)
2027 BioCapital Standard (2)
2027 BioMidwest Digital (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (11)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (5)
2027 Genetown Elite (2)
2027 Genetown Premier (1)
2027 Genetown Standard (8)
2027 Pharm Country Digital (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (11)
40 Under 40 (3)
Academia (1687)
Academic (1)
Accelerated approval (72)
ADA (43)
Adcomms (30)
Allergies (157)
Alliances (42354)
ALS (253)
Alzheimer's disease (1767)
Antibody-drug conjugate (ADC) (675)
Approvals (14943)
Artificial intelligence (701)
ASCO (307)
Autoimmune disease (461)
Automation (55)
Bankruptcy (302)
Belgium (35)
Best Places to Work (9324)
BIO (68)
Biologics (92)
BIOSECURE Act (13)
Biosimilars (218)
BioSpace Insights (88)
Biotechnology (163)
Bispecific (48)
Bladder cancer (229)
Brain cancer (93)
Breast cancer (889)
Cancer (7207)
Cardiovascular disease (555)
Career advice (417)
Career pathing (9)
CAR-T (455)
CDC (16)
CDMO (156)
Celiac Disease (7)
Cell therapy (1227)
Cervical cancer (51)
Clinical research (68919)
Collaboration (2400)
Commercialization (54)
Company closure (6)
Compensation (1742)
Complete response letters (91)
COVID-19 (1706)
CRISPR (143)
CRO (2)
C-suite (1358)
Cystic fibrosis (174)
Data (10018)
Decentralized trials (2)
Denatured (24)
Depression (194)
Dermatology (165)
Diabetes (692)
Diagnostics (5740)
Digital health (58)
Diversity (4)
Diversity, equity & inclusion (13)
Drug discovery (365)
Drug pricing (104)
Drug shortages (24)
Duchenne muscular dystrophy (365)
Earnings (82331)
Editorial (38)
Employer branding (6)
Employer resources (42)
ESMO (403)
Events (108040)
Executive appointments (1071)
Eye disease (20)
FDA (18676)
Fibrodysplasia Ossificans Progressiva (16)
Fragile X (6)
Friedreich's ataxia (28)
Frontotemporal dementia (39)
Funding (1875)
Gene editing (304)
Generative AI (55)
Gene therapy (971)
GLP-1 (931)
Government (2364)
Grass and pollen (4)
Guidances (382)
Healthcare (13930)
Hematology (209)
HIV (101)
Huntington's disease (86)
Idiopathic pulmonary fibrosis (14)
IgA nephropathy (141)
Immunology and inflammation (331)
Immuno-oncology (144)
Indications (273)
Infectious disease (2014)
Inflammatory bowel disease (251)
Inflation Reduction Act (8)
Influenza (108)
Intellectual property (333)
Interviews (65)
IPO (14427)
IRA (20)
Job creations (2485)
Job search strategy (379)
JPM (48)
Kidney cancer (24)
Kidney disease (153)
Labor market (30)
Layoffs (346)
Leadership (12)
Legal (5831)
Licensing (96)
Liver cancer (97)
Longevity (48)
Lung cancer (1013)
Lung diease (18)
Lymphoma (540)
Machine learning (54)
Management (9)
Manufacturing (1171)
Marketing (35)
MASH (231)
Medical affairs (3)
Medical device (10780)
Medtech (11025)
Mergers & acquisitions (17001)
Metabolic disorders (1698)
mRNA (242)
Multiple sclerosis (222)
Multispecific (4)
NASH (15)
Netherlands (30)
Neurodegenerative disease (549)
Neuropsychiatric disorders (118)
Neuroscience (3637)
Neurotech (3)
NextGen: Class of 2026 (4493)
Non-profit (2267)
Now hiring (26)
Obesity (751)
Opinion (196)
Ovarian cancer (277)
Pain (308)
Pancreatic cancer (405)
Parkinson's disease (431)
Partnered (32)
Patents (679)
Patient advocacy (4)
Patient recruitment (898)
Patient selection (95)
Peanut (53)
People (50432)
Peptides (26)
Pharmaceutical (40)
Pharmacy benefit managers (19)
Phase 1 (21754)
Phase 2 (30520)
Phase 3 (22359)
Pipeline (12620)
Policy (192)
Postmarket research (2351)
Preclinical (9159)
Press Release (66)
Prostate cancer (378)
Psychedelics (88)
Radioligand (3)
Radiopharmaceuticals (391)
Rare diseases (1492)
Real estate (4103)
Recruiting (18)
Regenerative medicine (28)
Regulatory (22071)
Reports (36)
Research institute (1957)
Resumes & cover letters (64)
Rett syndrome (59)
RNA editing (36)
RSV (63)
Schizophrenia (188)
Series A (343)
Series B (233)
Service/supplier (5)
Sickle cell disease (138)
Special edition (19)
Spinal muscular atrophy (193)
Sponsored (36)
Startups (2990)
Stem cells (8)
Stomach cancer (17)
Substance use disorders (19)
Supply chain (105)
Switzerland (11)
Tariffs (40)
Tax incentives (1)
The Weekly (109)
Vaccines (711)
Venture capital (103)
Weight loss (436)
Wet AMD (7)
Women's health (136)
Worklife (4)
Date
Today (11)
Last 7 days (990)
Last 30 days (2882)
Last 365 days (27982)
2026 (24406)
2025 (27480)
2024 (31571)
2023 (35307)
2022 (44889)
2021 (47754)
2020 (43431)
2019 (32912)
2018 (24734)
2017 (25819)
2016 (24592)
2015 (30587)
2014 (26107)
2013 (21885)
2012 (23699)
2011 (23955)
2010 (23482)
Location
Africa (416)
Alabama (99)
Alaska (5)
Arizona (396)
Arkansas (13)
Asia (30472)
Australia (4742)
California (15558)
Canada (4041)
China (1698)
Colorado (660)
Connecticut (631)
Delaware (408)
Europe (61964)
Florida (2279)
Georgia (483)
Hawaii (4)
Idaho (52)
Illinois (1104)
India (127)
Indiana (633)
Iowa (28)
Japan (679)
Kansas (126)
Kentucky (54)
Louisiana (56)
Maine (34)
Maryland (1716)
Massachusetts (11240)
Michigan (354)
Minnesota (740)
Mississippi (6)
Missouri (153)
Montana (28)
Nebraska (16)
Nevada (149)
New Hampshire (73)
New Jersey (3981)
New Mexico (26)
New York (3987)
North Carolina (1902)
North Dakota (13)
Northern California (8029)
Ohio (400)
Oklahoma (19)
Oregon (37)
Pennsylvania (2980)
Puerto Rico (30)
Rhode Island (50)
South America (609)
South Carolina (88)
South Dakota (1)
Southern California (6247)
Tennessee (188)
Texas (2581)
United States (53573)
Utah (468)
Vermont (1)
Virginia (310)
Washington D.C. (56)
Washington State (1246)
West Virginia (2)
Wisconsin (146)
Wyoming (1)
622,524 Results for "genetic therapy inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Opus Genetics Announces FDA Clearance of IND Application for OPGx-RDH12 Gene Therapy for Inherited Childhood Blindness
October 21, 2026
·
7 min read
ALS
Ionis-Otsuka offer ‘groundbreaking’ improvement in function and survival for genetic type of ALS
Ulefnersen, an RNA-targeted therapy being developed by Ionis Pharmaceuticals and Otsuka Pharmaceutical, improved measurements of functional impairment and survival in patients with a rare, genetic ALS subtype in a Phase 3 trial. The partners plan to approach the FDA with the results to determine potential pathways for approval.
September 23, 2026
·
4 min read
·
Heather McKenzie
Press Releases
Opus Genetics Completes Dosing in Cohort 2 of Phase 1/2 Clinical Trial of OPGx-BEST1 Gene Therapy for Inherited Retinal Diseases
November 5, 2026
·
8 min read
Gene Therapy
Intellia finds genetic suspect for liver safety signals with ATTR gene therapy
In November 2025, one patient died after receiving Intellia Therapeutics’ investigational gene silencer for transthyretin amyloidosis.
August 7, 2026
·
2 min read
·
Tristan Manalac
Press Releases
SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies
August 4, 2026
·
4 min read
Press Releases
Opus Genetics Presents Positive Clinical Data from OPGx-BEST1 and OPGx-LCA5 Gene Therapy Programs at Retina in Rio 2026
October 15, 2026
·
9 min read
Press Releases
Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
October 8, 2026
·
4 min read
Press Releases
Confluence Genetics Launches Cas-CLEAR™, a New CRISPR Technology Platform for Cancer Therapy
July 9, 2026
·
5 min read
Press Releases
SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
October 8, 2026
·
4 min read
Rett syndrome
Neurogene, Taysha near finish line in ‘two-horse race’ for first Rett syndrome gene therapy
As both Taysha Gene Therapies and Neurogene warm up for an important year of readouts, the Rett syndrome community is hopeful of seeing a therapy that can truly change the disease’s path.
October 26, 2026
·
6 min read
·
Michael Gibney
1 of 62,253
Next
